Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-30

Clinical Trial Update: Cerebrovascular Reserve and White Matter Disease in Patients with Chronic Anemia

View source ↗

Summary

Completed clinical trial assessing cerebrovascular reserve and white matter disease in patients with chronic anemia due to thalassemia or sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Hospital Los Angeles | Conditions: Thalassemia, Sickle Cell Disease | Status: COMPLETED